Intelligent Bio Solutions EBITDA 2020-2025 | INBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Intelligent Bio Solutions ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Intelligent Bio Solutions ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$143.6B
CVS Health (CVS)	$83.1B
Elevance Health (ELV)	$66.2B
Cencora (COR)	$55.3B
DiDi Global (DIDIY)	$26.1B
Labcorp Holdings (LH)	$22.1B
Natera (NTRA)	$20.7B
BioMerieux (BMXMF)	$17.7B
EUROFINS SCIENT (ERFSF)	$14.9B
CochLear (CHEOY)	$13.2B
ICON (ICLR)	$12.8B
Solventum (SOLV)	$12.7B
Medpace Holdings (MEDP)	$12.2B
Viatris (VTRS)	$11.4B
Revvity (RVTY)	$10.1B
Sonic Healthcare (SKHHY)	$9B
HealthEquity (HQY)	$8B
Avantor (AVTR)	$7.8B
Caris Life Sciences,�Inc (CAI)	$7.6B
Charles River Laboratories (CRL)	$7.3B
Bausch + Lomb (BLCO)	$4.8B
Sotera Health (SHC)	$4B
Amplifon S.p.A (AMFPF)	$3.9B
BrightSpring Health Services (BTSG)	$3.7B
Surgery Partners (SGRY)	$3B
GeneDx Holdings (WGS)	$3B
Alignment Healthcare (ALHC)	$2.9B
Concentras Parent (CON)	$2.8B
Organon (OGN)	$2.4B
Progyny (PGNY)	$2B